Sleep disturbances are widespread in AD patients and have been reported in various animal models of AD, including PS19 Tau transgenic AD/FTD mouse model (Holth et al., 2017; C. Wang and Holtzman, 2019; Kam et al., 2023; Morrone et al., 2023). The gene discussed is MAPT; the disease is Alzheimer disease.